Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 07, 2016 4:14 AM ET

Pharmaceuticals

Company Overview of Wacker Biotech GmbH

Company Overview

Wacker Biotech GmbH offers contract manufacturing of pharmaceutical proteins. Wacker Biotech GmbH was formerly known as Prothera GmbH. The company was founded in 1999 and is based in Jena, Germany. As of January 11, 2005, Wacker Biotech GmbH operates as a subsidiary of Wacker chemistry AG.

Hans Knöll Straße 3

Jena,  07745

Germany

Founded in 1999

Phone:

49 3641 65 8270

Fax:

49 3641 65 8271

Key Executives for Wacker Biotech GmbH

Wacker Biotech GmbH does not have any Key Executives recorded.

Wacker Biotech GmbH Key Developments

Wacker Biotech Announces License Agreement with MedImmune

Wacker Biotech GmbH has announced a license agreement with MedImmune, a biologics R&D arm of AstraZeneca, for the use of its ESETEC 2.0 proprietary secretion technology in E.coli. This agreement now gives MedImmune the right to use WACKER's ESETEC 2.0 cell line exclusively for the production and commercialization of an antibody fragment (Fab), which will benefit MedImmune with improved productivity and a simplified purification process as compared to conventional E. coli processes. This agreement follows a feasibility study that the companies conducted, which demonstrated that WACKER's ESETEC2.0 technology was superior to existing technologies for the production of Fabs. Fabs are purpose-made constituents of human antibodies and represent a highly promising growth area for the pharmaceutical industry. The ESETEC 2.0 technology provided a high yield of correctly folded and biologically active Fab. The technology also exhibited enhanced productivity, which outperformed industrially optimized processes for mammalian cell cultures (CHO cells). Based on this successful study, both parties agreed to produce the Fab at one of Wacker's cGMP (current Good Manufacturing Practice) facilities.

Wacker Biotech GmbH Presents at BIO International Convention 2015, Jun-18-2015 02:45 PM

Wacker Biotech GmbH Presents at BIO International Convention 2015, Jun-18-2015 02:45 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.

Wacker Biotech GmbH Presents at BIO-Europe 2014, Nov-04-2014 05:45 PM

Wacker Biotech GmbH Presents at BIO-Europe 2014, Nov-04-2014 05:45 PM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany.

Similar Private Companies By Industry

Company Name Region
Curadis GmbH Europe
InflaRx GmbH Europe
MSD Regional Business Support Center GmbH Europe
Responsif Gmbh Europe
Biogen Idec GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Wacker Biotech GmbH, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.